SUPPLEMENTARY MATERIALS
Supplementary Figure 1: Impact of Orai1 inhibitor, GSK-7975A in calcium entries. (A) Store-operated Ca 2+ entry in 32d-p210 cell line in control condition (dotted line) and in presence of 1 µM GSK-7975A (dark line). The ER depletion was obtained by perfusion of 15 μM CPA (SERCA inhibitor) in 0 mM Ca 2+ solution, which allowed SOCE recording in presence of 1.8 mM Ca 2 prior to a 0 mM Ca 2+ buffer incubation. (B) SOCE measurements (initial slope of intracellular Ca 2+ rise) in p210-32d cells in control condition or after incubation of 10 µM YM 58483 or 1 µM GSK-7975A for 30 min. This experiment was done also with 10 µM GSK-7975A but no calcium entries could be measured showing a total SOCE inhibition in this experimental condition. (C) Quantification of half-time response of thrombin-induced Ca 2+ transient with or without pre-incubation with 10 µM GSK-7975A during 30 minutes and incubated with 1 U/ml thrombin in 1.8 mM Ca 2+ buffer in WT and 32d-p210 cells. The duration of the thrombin-induced Ca 2+ transient is more dependent on SOCE in WT cells than in 32d-p210 cells. Bar graphs represent mean rates ± SEM.
* P < 0.01; ** P < 0.005; ***
